Strata Critical Medical, Inc.
IndustrialsNASDAQ:SRTA · NASDAQ Global Market
-$0.06 today
Vol 1.52M · Avg 0.82M
Management
Put operating results in leadership context
Review returns on capital, executive background, insider transactions, and growth quality to judge whether management is compounding value well.
Return Metrics
ROE, ROIC & ROA over time
ROE
-5.6%
avg -53.4%
ROIC
-3.2%
avg -21.5%
ROA
-4.8%
avg -16.6%
Analysis
ROIC is currently the strongest return metric at -3.2% versus its period average of -21.5%. 0 of 3 return metrics are above their quality threshold, which helps indicate how efficiently the company turns capital and assets into profit.
Management
Key executives, compensation & ownership
| Name | Title | Compensation | Tenure | Age | Shares Owned | Ownership % |
|---|---|---|---|---|---|---|
Melissa Tomkiel | Co- CEO, General Counsel, Corporate Secretary & Director | $1.13M | — | 45 | $1.89M | 2.19% |
William A. Heyburn | Co-CEO, CFO & Director | $1.10M | — | 37 | $1.55M | 1.79% |
Scott Wunsch | Chief Executive Officer of Logistics Services | $829,594.00 | — | 49 | $625,574.00 | 0.72% |
Amir Cohen | Chief Accounting & Integration Officer | $596,000.00 | — | 49 | $146,608.00 | 0.17% |
Scott Silvestry | Chief Medical Officer | — | — | — | $625,574.00 | 0.72% |
Keith Trepanier | Chief of Safety | — | — | — | — | — |
Louis Verdetto | Chief Executive Officer of Clinical Services | — | — | 42 | $132,232.00 | 0.15% |
Mathew Schneider | CFO of Clinical Services & VP of Finance and Investor Relations | — | — | — | — | — |
Insider Trading
SEC Form 4 transactions — last 12 months
Buys
2
$97,869.40
Sells
11
$1.37M
Net Sentiment
$1.27M
Net selling
Most Active
Cohen Amir
4 transactions
1–10 of 13
Analysis
Insiders reported 2 buys worth $97,869.40 and 11 sells worth $1.37M over the last 12 months. That adds up to net selling of $1.27M. Cohen Amir was the most active insider with 4 transactions.
Growth Analysis
Historical CAGR & forward analyst estimates
| Metric | 10yr | 5yr | 3yr | Fwd Est. |
|---|---|---|---|---|
| EPS | N/A | N/A | N/A | N/A1 analysts |
| Revenue | N/A | N/A | +112.6% | +7.1% (5yr)1 analysts |
| Net Income | N/A | N/A | N/A | N/A1 analysts |
| EBIT | N/A | N/A | N/A | N/A1 analysts |
Analysis
Recent growth has been strongest in Revenue at +112.6% over three years. Forward estimates point to Revenue at +7.1% (5yr), giving you a quick check on whether expectations are accelerating or cooling.
Competitors
Peer companies in the same sector
Kforce Inc.
NYSE:KFRC
$891.60M
Cryoport, Inc.
NASDAQ:CYRX
$736.88M
Orion Group Holdings, Inc.
NYSE:ORN
$587.35M
Ennis, Inc.
NYSE:EBF
$524.94M
Universal Logistics Holdings, Inc.
NASDAQ:ULH
$451.98M
Matrix Service Company
NASDAQ:MTRX
$385.71M
ZipRecruiter, Inc.
NYSE:ZIP
$311.43M
AIRO Group Holdings, Inc. Common Stock
NASDAQ:AIRO
$252.51M
Vertical Aerospace Ltd.
NYSE:EVTL
$216.93M
flyExclusive, Inc.
AMEX:FLYX
$162.18M
Who manages SRTA?
Strata Critical Medical, Inc. (SRTA) lists 8 active executives. The top listed executive is William A. Heyburn, Co-CEO, CFO & Director.
Are SRTA insiders buying or selling?
Recent insider activity shows net selling of $45.95M.
Explore More
Continue the stock analysis
Jump to another research area for this company.